clopidogrel has been researched along with Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dessing, MC; Emal, D; Florquin, S; Jansen, MP; Roelofs, JJ; Teske, GJ | 1 |
| Madanick, RD | 1 |
1 review(s) available for clopidogrel and Nephritis
| Article | Year |
|---|---|
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Topics: Anemia, Iron-Deficiency; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Fractures, Spontaneous; Gastroesophageal Reflux; Humans; Nephritis; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Vitamin B Deficiency | 2011 |
1 other study(ies) available for clopidogrel and Nephritis
| Article | Year |
|---|---|
Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps.
Topics: Animals; Blood Platelets; Cell Line; Clopidogrel; Disease Models, Animal; DNA; Epithelial Cells; Extracellular Traps; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules; Male; Mice, Inbred C57BL; Nephritis; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Factor 4; Reperfusion Injury; Signal Transduction; Ticlopidine; Time Factors | 2017 |